A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial

Sai‐Hong Ignatius Ou, Marianna Koczywas, Susanna V. Ulahannan, Pasi A. Jänne, Jorge H. Limón-Pacheco, Howard A. Burris, Caroline E. McCoach, J.S. Wang, Michael S. Gordon, Eric B. Haura, Jonathan W. Riess, Viola W. Zhu, Kimmie Ng, S. Gail Eckhardt, Anna Capasso, Richa Dua, A. Chen, Z. Wang, Josie Hayes, R. Jeremy Nichols, Trever G. Bivona